CN110452930A - A kind of genome edit methods and purposes based on immunocyte - Google Patents

A kind of genome edit methods and purposes based on immunocyte Download PDF

Info

Publication number
CN110452930A
CN110452930A CN201910764807.5A CN201910764807A CN110452930A CN 110452930 A CN110452930 A CN 110452930A CN 201910764807 A CN201910764807 A CN 201910764807A CN 110452930 A CN110452930 A CN 110452930A
Authority
CN
China
Prior art keywords
immunocyte
sequence
genome
methods based
edit methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910764807.5A
Other languages
Chinese (zh)
Inventor
陈相波
雷鸣
田朋飞
应荣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hangzhou Rong Biotechnology Co Ltd
Original Assignee
Hangzhou Rong Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hangzhou Rong Biotechnology Co Ltd filed Critical Hangzhou Rong Biotechnology Co Ltd
Priority to CN201910764807.5A priority Critical patent/CN110452930A/en
Publication of CN110452930A publication Critical patent/CN110452930A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a kind of genome edit methods based on immunocyte, including designing the genome of immunocyte, the genome edit tool of specified site sequence, the gene editing of immunocyte and fixed point gene knock-in integration;The gene editing of the immunocyte refer to based on nickase generate DNA single stranded gaps technology, be aided with a set of homologous recombination factors RecOFAR realize it is efficient, accurate, fixed point human primary cultured cells genome editor.The present invention significantly improves the safety of genome editor, reduces error rate;Adjustable point gene knock-in.

Description

A kind of genome edit methods and purposes based on immunocyte
Technical field
The present invention relates to genome editing technique field, specially a kind of genome edit methods based on immunocyte and Purposes.
Background technique
Gene editing technology refers to that the mankind is allowed to carry out " editor " to target gene, and specific DNA segment is struck in realization It removes, be added.And CRISPR/Cas9 technology since the advent of the world, just there are other unrivaled advantages of gene editing technology, skill After art is continuously improved, be more believed in living cells it is most effective, most easily " edit " any gene.
Gene editing technology carries out precise manipulation to target gene, realizes site-directed point mutation, insertion, deletion, straight with this It connects starting, close certain genes, or even directly Disease-causing gene edited in molecular level, modified, thus to unknown function Gene carries out the technology of research and gene therapy.The most commonly used gene editing technology is to identify to target based on Cas9 recombinase SgRNA sequence determines specified gene location, the gene editing being then oriented.Direct editing dcc gene can be passed through at present Make its normal expression in body cell, changing genetic defect patient can not cure, can only rely on the status taken medicine all the life.Currently, Gene editing technology obtains certain progress in the diseases such as tyrosinemia, β-thalassemia, has successfully cured trouble There is the adult mice of tyrosinemia, which in vivo demonstrates its curative effect for treating genetic deficiency diseases in Adult Mammals And safety, it is an important breakthrough of human gene therapy.
In order to preferably be edited to genome, it is proposed that a kind of genome edit methods based on immunocyte.
Summary of the invention
The present invention provides a kind of genome edit methods based on immunocyte and can effectively solve in above-mentioned background technique The problem of.
To achieve the above object, the invention provides the following technical scheme: a kind of genome editing side based on immunocyte Method, including design the genome of immunocyte, the genome edit tool of specified site sequence, immunocyte gene editing and Fixed point gene knock-in integration and etc.;The gene editing of the immunocyte, which refers to, generates DNA single stranded gaps with based on nickase Technology, be aided with a set of homologous recombination factors RecOFAR realize it is efficient, accurate, fixed point human primary cultured cells' gene Group editor.
Further, the genome edit tool is Cas9 system.
Further, a kind of genome edit methods based on immunocyte, comprising the following steps:
A, the preparation of wild type Cas9 and the preparation of sgRNA, but it is not limited to Cas9 enzyme, it further include other any DNA mono- Chain nickase;
B, potential nicks at positioning integration target target site;
C, foreign donor DNA profiling is designed;
D, preparation and the recombinant factor group RecOFAR in system of the present invention is provided;
E, turn human primary cultured cells using electricity and carry out pinpoint gene editing, transformation.
Further, the preparation of the wild type Cas9 and sgRNA: wild type Cas9 sequence is separately added into nuclear localization sequence, Then SP6 promoter sequence is added in the upstream of whole section of sequence, is capped using the kit of in-vitro transcription and adds polyA's MRNA obtains Cas9mRNA, freezes after being mixed with various combination spare;SgRNA synthesizes upstream by DNA and has T7 promoter sequence It arranges and there are the downstream sequence of partial complementarity with upstream, obtain double-stranded DNA by PCR amplification, utilize the kit of in-vitro transcription It obtains.
Further, potential nicks at the positioning integration target target site: the selected site nick, integration site are selected in On nucleotide at the site nick or between the collaboration site nick.
Further, the design foreign donor DNA profiling: in upstream, there is the homologous sequence i.e. upstream of 1kb in the upstream of nick Homology arm, in downstream, there is the homologous sequence i.e. downstream homology arm of 1kb in the downstream of nick;It is added at integration site and knocks in element; Extracting plasmid by amplification becomes foreign donor DNA.
Further, each recombinant factor sequence is separately added into nuclear localization sequence, is then added in the upstream of whole section of sequence SP6 promoter sequence is capped using the kit of in-vitro transcription and is added the mRNA of polyA, after being mixed with various combination- 80 DEG C freeze it is spare.
Further, the gene editing human immune cells: using electric shifting method by compound used in gene targeting press than Example requires to import people's primary immune cells.
Further, the immunocyte is set as lymphocyte, Dendritic Cells, Monocytes/Macrophages, granulocyte or fertilizer Maxicell.
Compared with prior art, beneficial effects of the present invention: the present invention significantly improves the safety of genome editor, reduces Error rate;Adjustable point gene knock-in.
Specific embodiment
It, below will be to the embodiment of the present invention to keep the purposes, technical schemes and advantages of embodiment of the present invention clearer In technical solution be clearly and completely described, it is clear that described embodiments are only a part of the embodiments of the present invention, Instead of all the embodiments.Based on the embodiments of the present invention, those of ordinary skill in the art are not making creative labor Every other embodiment obtained under the premise of dynamic, shall fall within the protection scope of the present invention.
The present invention provides a kind of genome edit methods based on immunocyte, including design immunocyte genome, The genome edit tool of specified site sequence, the gene editing of immunocyte and fixed point gene knock-in integration and etc.;It is described The gene editing of immunocyte refer to based on nickase generate DNA single stranded gaps technology, be aided with a set of homologous recombination factors RecOFAR come realize it is efficient, accurate, fixed point human primary cultured cells genome editor.
Further, the genome edit tool is Cas9 system.
Further, a kind of genome edit methods based on immunocyte, comprising the following steps:
A, the preparation of wild type Cas9 and the preparation of sgRNA, but it is not limited to Cas9 enzyme, it further include other any DNA mono- Chain nickase;
B, potential nicks at positioning integration target target site;
C, foreign donor DNA profiling is designed;
D, preparation and the recombinant factor group RecOFAR in system of the present invention is provided;
E, turn human primary cultured cells using electricity and carry out pinpoint gene editing, transformation.
Further, the preparation of the wild type Cas9 and sgRNA: wild type Cas9 sequence is separately added into nuclear localization sequence, Then SP6 promoter sequence is added in the upstream of whole section of sequence, is capped using the kit of in-vitro transcription and adds polyA's MRNA obtains Cas9mRNA, freezes after being mixed with various combination spare;SgRNA synthesizes upstream by DNA and has T7 promoter sequence It arranges and there are the downstream sequence of partial complementarity with upstream, obtain double-stranded DNA by PCR amplification, utilize the kit of in-vitro transcription It obtains.
Further, potential nicks at the positioning integration target target site: the selected site nick, integration site are selected in On nucleotide at the site nick or between the collaboration site nick.
Further, the design foreign donor DNA profiling: in upstream, there is the homologous sequence i.e. upstream of 1kb in the upstream of nick Homology arm, in downstream, there is the homologous sequence i.e. downstream homology arm of 1kb in the downstream of nick;It is added at integration site and knocks in element; Extracting plasmid by amplification becomes foreign donor DNA.
Further, each recombinant factor sequence is separately added into nuclear localization sequence, is then added in the upstream of whole section of sequence SP6 promoter sequence is capped using the kit of in-vitro transcription and is added the mRNA of polyA, after being mixed with various combination- 80 DEG C freeze it is spare.
Further, the gene editing human immune cells: using electric shifting method by compound used in gene targeting press than Example requires to import people's primary immune cells.
Further, the immunocyte is set as lymphocyte, Dendritic Cells, Monocytes/Macrophages, granulocyte or fertilizer Maxicell.
Finally, it should be noted that being not intended to restrict the invention the foregoing is merely preferred embodiment of the invention, to the greatest extent Present invention has been described in detail with reference to the aforementioned embodiments for pipe, for those skilled in the art, still can be with It modifies the technical solutions described in the foregoing embodiments or equivalent replacement of some of the technical features.It is all Within the spirit and principles in the present invention, any modification, equivalent replacement, improvement and so on should be included in guarantor of the invention Within the scope of shield.

Claims (9)

1. a kind of genome edit methods based on immunocyte, which is characterized in that including designing the genome of immunocyte, referring to The genome edit tool of positioning point sequence, the gene editing of immunocyte and fixed point gene knock-in integration and etc.;It is described to exempt from The gene editing of epidemic disease cell refer to based on nickase generate DNA single stranded gaps technology, be aided with a set of homologous recombination factors RecOFAR come realize it is efficient, accurate, fixed point human primary cultured cells genome editor.
2. a kind of genome edit methods based on immunocyte according to claim 1, it is characterised in that: the gene Group edit tool is Cas9 system.
3. a kind of genome edit methods based on immunocyte according to claim 1, it is characterised in that: including following Step:
A, the preparation of wild type Cas9 and the preparation of sgRNA, but be not limited to Cas9 enzyme, further include other any DNA is single-stranded cuts Mouth enzyme;
B, potential nicks at positioning integration target target site;
C, foreign donor DNA profiling is designed;
D, preparation and the recombinant factor group RecOFAR in system of the present invention is provided;
E, turn human primary cultured cells using electricity and carry out pinpoint gene editing, transformation.
4. a kind of genome edit methods based on immunocyte according to claim 3, it is characterised in that: described wild The preparation of type Cas9 and sgRNA: wild type Cas9 sequence is separately added into nuclear localization sequence, is then added in the upstream of whole section of sequence SP6 promoter sequence is capped and is added using the kit of in-vitro transcription the mRNA of polyA, Cas9 mRNA obtained, with not It is spare with being frozen after combined hybrid;SgRNA synthesizes upstream with T7 promoter sequence by DNA and there are partial complementarities with upstream Downstream sequence, obtain double-stranded DNA by PCR amplification, obtained using the kit of in-vitro transcription.
5. a kind of genome edit methods based on immunocyte according to claim 4, it is characterised in that: the positioning Potential nicks at conformity goal target site: the selected site nick, integration site are selected at the site nick or cooperate with the site nick Between nucleotide on.
6. a kind of genome edit methods based on immunocyte according to claim 5, it is characterised in that: the design Foreign donor DNA profiling: in upstream, there are the homologous sequence i.e. upstream homology arm of 1kb, the downstream of nick in downstream in the upstream of nick There is the homologous sequence i.e. downstream homology arm of 1kb;It is added at integration site and knocks in element;Extracting plasmid by amplification becomes external source Donor dna.
7. a kind of genome edit methods based on immunocyte according to claim 6, it is characterised in that: described each heavy Group factor sequence is separately added into nuclear localization sequence, and SP6 promoter sequence then is added in the upstream of whole section of sequence, is turned using external The kit of record be capped and add polyA mRNA, after being mixed with various combination -80 DEG C freeze it is spare.
8. a kind of genome edit methods based on immunocyte according to claim 6, it is characterised in that: the gene Editor human immune cells: require importing people's primary immune thin in proportion compound used in gene targeting using electric shifting method Born of the same parents.
9. a kind of genome edit methods based on immunocyte according to claim 1, it is characterised in that: described immune Cell is set as lymphocyte, Dendritic Cells, Monocytes/Macrophages, granulocyte or mast cell.
CN201910764807.5A 2019-08-19 2019-08-19 A kind of genome edit methods and purposes based on immunocyte Pending CN110452930A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910764807.5A CN110452930A (en) 2019-08-19 2019-08-19 A kind of genome edit methods and purposes based on immunocyte

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910764807.5A CN110452930A (en) 2019-08-19 2019-08-19 A kind of genome edit methods and purposes based on immunocyte

Publications (1)

Publication Number Publication Date
CN110452930A true CN110452930A (en) 2019-11-15

Family

ID=68487653

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910764807.5A Pending CN110452930A (en) 2019-08-19 2019-08-19 A kind of genome edit methods and purposes based on immunocyte

Country Status (1)

Country Link
CN (1) CN110452930A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108949830A (en) * 2018-08-03 2018-12-07 福州大学 A method of realizing genome editor, pinpoint gene knock-in in fish
CN108998406A (en) * 2018-08-03 2018-12-14 福州大学 A kind of human primary cultured cells' genome editor, fixed point gene knock-in method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108949830A (en) * 2018-08-03 2018-12-07 福州大学 A method of realizing genome editor, pinpoint gene knock-in in fish
CN108998406A (en) * 2018-08-03 2018-12-14 福州大学 A kind of human primary cultured cells' genome editor, fixed point gene knock-in method

Similar Documents

Publication Publication Date Title
Antoniou et al. Base and prime editing technologies for blood disorders
CN108753783A (en) The construction method of Sqstm1 full genome knock-out mice animal models and application
KR20220162168A (en) Treatment methods and drugs for Hurler syndrome
CN105567735A (en) Site specific repairing carrier system and method of blood coagulation factor genetic mutation
AU2016381313A1 (en) Compositions and methods for the treatment of hemoglobinopathies
JP2019508051A (en) CRISPR / CAS-related methods and compositions for treating beta-hemoglobinopathy
CN104404036A (en) Conditional gene knockout method based on CRISPR/Cas9 technology
Wulff et al. Substitutional A‐to‐I RNA editing
CN104284669A (en) Compositions and methods for the treatment of hemoglobinopathies
CN112029765A (en) Method for making Metrnl gene conditional knockout mouse model
WO2018045727A1 (en) Method for constructing an animal model for mucopolysaccharidosis type ii, and applications thereof
CN105624196A (en) Method for establishing CYP2C11 gene knockout rat model
Fang et al. Treatment of β654‐thalassaemia by TALEN s in a mouse model
US20240175056A1 (en) Prime editing-based simultaneous genomic deletion and insertion
Chao et al. Precise and rapid validation of candidate gene by allele specific knockout with CRISPR/Cas9 in wild mice
CN105624191A (en) Method for establishing CYP2D1 gene knockout rat model
DE69737996D1 (en) METHODS FOR PRODUCING NUCLEOTIDINE TREATS
Yang et al. Production of CFTR-ΔF508 rabbits
CN110452930A (en) A kind of genome edit methods and purposes based on immunocyte
CN112442516A (en) Method for efficiently repairing gene mutation of cricoid sideroblasts
US20220033857A1 (en) Editing of haemoglobin genes
CN114591957B (en) Construction method and application of severe hemophilia A animal model
CN112391410B (en) sgRNA and application thereof in repairing abnormal splicing of introns
CN114457114A (en) Construction method of Fars2 gene conditional knockout animal model
CN114410630A (en) Construction method and application of TBC1D8B gene knockout mouse animal model

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20191115

RJ01 Rejection of invention patent application after publication